About Us
Accelerating drug development with integrated CDMO/CRO services for over three decades.
Who are Quotient Sciences?
Quotient Sciences has worked with customers as a trusted partner, providing contract research and contract manufacturing expertise across all stages of small molecule and synthetic peptide drug development for the last 30 years. Learn more about who we are and the value we bring, driven by our mission to improve global health and bring molecules to cures, fast, for those in need.
Multiyear Winner of CRO Leadership Awards
Most recently in 2024, for our excellence in conducting Phase I clinical studies for small molecule and synthetic peptide drug programs.
Winner of 2023 CDMO Leadership Awards
Recognizing top performing outsourcing organizations in the drug development space.
Winner of 2024 Fierce CRO Awards
Recognized for "Innovative Solutions in Drug Development" for the Translational Pharmaceutics platform for drug development.